David A. Siegel Johnson & Johnson Transaction History

Two Sigma Advisers, LP

$42.5 Billion
Q1 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Johnson & Johnson stock. As of the latest transaction made, Two Sigma Advisers, LP holds 748,509 shares of JNJ stock, worth $110 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

748,509

Previous 2,080,009 64.01%

Holding current value

$110 Million

Previous $326 Million 63.68%

% of portfolio

0.28%

Previous 0.77%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $207 Million - $217 Million	-1,331,500 Reduced 64.01%	748,509 $118 Million
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $279 Million - $304 Million	1,915,200 Added 1162.07%	2,080,009 $326 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $131 Million - $147 Million	-843,191 Reduced 83.65%	164,809 $25.7 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $278 Million - $300 Million	-1,803,200 Reduced 64.14%	1,008,000 $167 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $30.2 Million - $36.1 Million	-200,100 Reduced 6.64%	2,811,200 $436 Million

Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $17 Million - $19.1 Million	-106,400 Reduced 3.41%	3,011,300 $532 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $155 Million - $172 Million	959,400 Added 44.45%	3,117,700 $509 Million
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $34.2 Million - $37.9 Million	-203,500 Reduced 8.62%	2,158,300 $383 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $130 Million - $148 Million	-825,100 Reduced 25.89%	2,361,800 $419 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $12.8 Million - $14.2 Million	-82,100 Reduced 2.51%	3,186,900 $545 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $70 Million - $77.8 Million	433,400 Added 15.28%	3,269,000 $528 Million
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $23.1 Million - $24.8 Million	145,100 Added 5.39%	2,835,600 $467 Million
Q1 2021 May 17, 2021	BUY	$153.07 - $170.48 $378 Million - $421 Million	2,471,000 Added 1125.74%	2,690,500 $442 Million
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $14 Million - $16.1 Million	-102,148 Reduced 31.76%	219,500 $34.5 Million
Q3 2020 Nov 16, 2020	SELL	$140.38 - $153.83 $77.2 Million - $84.6 Million	-550,117 Reduced 63.1%	321,648 $47.9 Million
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $42.3 Million - $51.1 Million	-328,500 Reduced 27.37%	871,765 $123 Million
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $307 Million - $426 Million	-2,764,400 Reduced 69.73%	1,200,265 $157 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $64.6 Million - $74.2 Million	-506,700 Reduced 11.33%	3,964,665 $578 Million
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $65.1 Million - $72.9 Million	512,800 Added 12.95%	4,471,365 $579 Million
Q2 2019 Aug 14, 2019	BUY	$131.15 - $144.24 $288 Million - $317 Million	2,195,200 Added 124.49%	3,958,565 $551 Million
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $95.3 Million - $106 Million	-758,100 Reduced 30.07%	1,763,365 $247 Million
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $54.7 Million - $65.8 Million	445,000 Added 21.43%	2,521,465 $325 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $118 Million - $139 Million	-972,800 Reduced 31.9%	2,076,465 $287 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $352 Million - $388 Million	2,947,200 Added 2887.57%	3,049,265 $370 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $12.8 Million - $15.1 Million	102,065 New	102,065 $13.1 Million
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $31.5 Million - $34.5 Million	-240,232 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $31.1 Million - $32.5 Million	240,232	240,232 $31.2 Million

Others Institutions Holding JNJ

# of Institutions

4,144

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $385B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account